Rare diseases
Investigational molecules
Locations
Chemin Des Aulx 14, 1228
Clinical research activity includes Alport syndrome, with a focus on renal disease and related glomerular injury. The sponsor’s portfolio in this area centers on therapeutic interest in kidney function and disease progression.
Research in this field reflects involvement in conditions where proteinuria, fibrosis, and declining kidney performance are clinically important.
Calliditas Therapeutics Suisse S.A. runs clinical trials in conditions such as Squamous cell carcinoma of head and neck, Alport's syndrome, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
France
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
